期刊文献+

动物眼部新生血管模型的研究进展 被引量:3

Research progress on ocular animal models for angiogenesis
原文传递
导出
摘要 随着新生血管性眼病治疗的发展,建立可靠性强、可重复性高的动物新生血管模型日益受到重视。常见的眼前节新生血管造模方法包括角膜微囊袋法、碱烧伤法和缝线法等。其中角膜微囊袋法通过植入目的药物分子,主要用于研究新生血管中特定的分子或蛋白;碱烧伤法和缝线法则更切实地模仿人类眼部疾病的发生过程。眼后段新生血管造模方法包括激光诱导脉络膜新生血管、缺氧诱导病理性新生血管和注射诱导炎症性新生血管等。此外,基因敲除或基因转导小鼠也成为研究新生血管中某特殊蛋白质作用的有力工具。f国际眼科纵览,2013,37:43-47) Increasing interest in developing reliable and reproducible models to study angiogenesis has emerged due to the large development of ocular neovascularization treatments. This review provides a summary of the principal ocular animal models for angiogenesis study. Models of anterior segment neovascu- larization include the corneal micropoeket assay, used to study the influence of specific molecules/proteins in angiogenesis and corneal chemical or suture induced injury, which mimic more closely the complex nature of the human disease. Angiogenesis models of the posterior segment include the well known laser-induced injury of the choroid/Bruchg membrane as well as the oxygen induced retinopathy and models of injections of pro- angiogenic/inflammatory molecules. In addition, knockout or knock-in transgenic mice provide powerful tools in studying the role of specific proteins in angiogenesis. (Int Rev Ophthalmol, 2013, 37: 43-47)
作者 顾顺 武志峰
出处 《国际眼科纵览》 2013年第1期43-47,共5页 International Review of Ophthalmology
关键词 新生血管形成 动物模型 碱性成纤维细胞生长因子 血管内皮生长因子 angiogenesis animal models basic fibroblast growth factor (bFGF) vascular endo- thelial growth factor (VEGF)
  • 相关文献

参考文献26

  • 1Gimbrone MA, Leapman SB, Cotran RS, et al. Tumor dormancy in vivo by prevention of neovascularization. J Exp Med, 1972, 136 : 261-276.
  • 2Ryan SJ. The development of an experimental model of sub-retinal neovascularization in disciform macular degeneration. Trans Am Ophthalmol Soc, 1979, 77: 707-745.
  • 3Miller JW, Walsh AW, Kramer M, et al. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol, 1995, 113 : 810-818.
  • 4Virdi PS, Hayreh SS. Ocular neovascularization with retinal vascular occlusion. I. Association with experimental retinal vein occlusion. Arch Ophthalmol, 1982, 100 : 331-341.
  • 5Kenyon BM, Voest EE, Chen CC, et al. A model of angiogenesis in the mouse cornea. Invest OphthalmoI Vis Sci, 1996, 37: 1625- 1632.
  • 6Poche RA, Saik JE, West JL, et al. The mouse cornea as a trans- plantation site for live imaging of engineered tissue constructs. Cold Spring Harb Protoe, 2010 ( April), doi: 10. ll01/pdb. prot5416.
  • 7赵卉,易正芳,胡宏慧,许迅.生物信息学筛选的合成小肽抑制小鼠角膜新生血管的实验研究[J].中华眼科杂志,2007,43(2):151-157. 被引量:5
  • 8Rogers MS, Birsner AE, D'Amato RJ. The mouse cornea micro- pocket angiogenesis assay. Nat Protoc, 2007, 2: 2545-2550.
  • 9Corrent G, Roussel TJ, Tseng SC, et al. Promotion of graft survival by phntothrombotic occlusion of corneal neovascularization. Arch Ophthalmol, 1989, 107: 1501-1506.
  • 10Zhanrong Li, Lin Yao, Jingguo Li, et al. Celastrol nanoparticles inhibit corneal neovascularization induced by suturing in rats. Int J Nanomedicine, 2012, 7 : 1163-1173.

二级参考文献33

  • 1Adamis AP,Shima DT.The role of vascular endothelial growth factor in ocular health and disease[J].Retina,2005,25(2):111-118.
  • 2Ferra N,Houck K,Jakeman L,et al.Molecular and biological properties of the vascular endothelial growth factor family of proteins[J].Endocr Rev,1992,13(1):18-32.
  • 3Miller KD,Chap LI,Holmes FA,et al.Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer[J].Clin Oncol,2005,23(4):792-799.
  • 4Yang JC,Haworth L,Sherry RM,et al.A randomized trial of bevacizumab,an anti-VEGF antibody,for metastatic renal cancer[J].N Engl J Med,2003,349(5):427-434.
  • 5Kang S,Chung SK.The effect of subconjunctival combined treatment of bevacizumab and triamcinolone acetonide on corneal neovascularization in rabbits[J].Cornea,2010,29(2):192-196.
  • 6Bahar I,Kaiserman I,McAllum P,et al.Subconjunctival bevacizumab injection for corneal neovascularization[J].Cornea,2008,27(2):142-147.
  • 7Nakao S,Hata Y,Miura M,et al.Dexamethasone inhibits interleukin-1β-induced corneal neovascularization[J].Am J Pathol,2007,171(3):1058-1065.
  • 8Biswas PS,Banerjee K,Kinchington PR,et al.Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection[J].Exp Eye Res,2006,82(1):46-54.
  • 9Lu P,Li L,Liu G,et al.Opposite roles of CCR2 and CX3CR1 macrophages in alkali-induced corneal neovascularization[J].Cornea,2009,28(5):562-569.
  • 10Lim P,Fuchsluger TA,Jurkunas UV.Limbal stem cell deficiency and corneal neovascularization[J].Seminars in Ophthalmology,2009,24(3):139-148.

共引文献10

同被引文献31

  • 1Lin Liu, Yong-Ping Li, Bo Zhang,,Wen-Xin Zhang.Auto-cortex of crystalline lens-induced iris neovascularization[J].International Journal of Ophthalmology(English edition),2012,5(1):23-27. 被引量:1
  • 2陈虹,刘磊,张风,魏文斌,彭晓燕,王书华,田蓓,华琳.肝细胞生长因子在糖尿病新生血管性青光眼玻璃体内含量的对比研究[J].眼科,2007,16(1):40-43. 被引量:4
  • 3李希波,孙雪飞,尹秋伟,王德江.熊果酸体内抗肺癌作用机制探讨[J].山东大学学报(医学版),2007,45(2):188-191. 被引量:16
  • 4王婷,宋怀燕,赵德明.福安特抗小鼠移植性肿瘤的实验研究I[J].中国兽医杂志,2007,43(7):28-29. 被引量:4
  • 5Sch/ffer G, Cramer T, Suske G, et al. Oxidative stress regulates vas- cular endothelial growth factor-A gene transcription through Spl- and Sp3-dependent activation of two proximal GC-rich promoter el- ements[ J]. J Biol Chem,2003,278(10) :8190-8198.
  • 6Bikul D, Herman Y, Rika T, et al. A hypoxia-driven vascular endo- thelial growth factor/Fit-1 autocrine loop interacts with hypoxia-in- ducible factor-1 α through mitogen-activated protein kinase/extra- cellular signal-regulated kinasel/2 pathway in neuroblastoma[ J]. Cancer Res ,2005,65 ( 16 ) :7267-7275.
  • 7Milkiewicz M, Ispanovic E, Doyle J. Regulators of angiogenesis and strategies for their thereapeutic manipulation [ J ]. J Biochem Cell Biol,2006,38 ( 3 ) : 333-357.
  • 8Kanjoormana M, Kuttan G. Antiangiogenic activity of ursolic acid [ J]. Integr Cancer Ther,2010,9 (2) :224-235.
  • 9Zhang L, Gong B, Hatala DA, et al. Retinal ischemia and reperfu- sion causes capillary degeneration:similarities to diabetes [ J ]. In- vest Ophthalmol Vis Sci,2007,48( 1 ) :361-367.
  • 10Bekowitz B A, Roberts R, Luan H, et al. Drug intervention can correct subnormal retinal oxygenation response in experimental diabetic retinophathy [ J ]. Invest Ophthalmol Vis Sci, 2005,46 (8) :2954-2960.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部